TMS has a strong track record for treatment-resistant depression — the group that has often been let down by medication. Here's what the published data shows and how we measure your progress.
In published outcome data, roughly 80% of patients with major depressive disorder respond to TMS (a meaningful reduction in symptoms) and about 63% achieve remission (symptoms largely resolved). These figures are notable because they apply to people who had already tried medications without sufficient relief.
Source: TMS device manufacturer's published registry data. Individual results vary.
We don't rely on impressions alone. Your psychiatrist uses validated depression rating scales at intake and at intervals during your course, so improvement is tracked with real numbers. This lets us adjust your protocol during treatment rather than waiting until the end.
TMS is effective, not magic. Some patients feel better within a few weeks; others improve gradually across the full course. A minority don't respond, and for them we discuss alternatives. Results also tend to be durable, and maintenance sessions are available if symptoms return down the road.
In manufacturer registry data, about 80% of patients respond and roughly 63% reach remission. These outcomes are for people with treatment-resistant depression. Individual results vary.
Your psychiatrist uses validated depression rating scales at intake and at intervals during your course, so progress is measured objectively and the plan can be adjusted.
Maintenance TMS sessions are available. Many patients who relapse later respond well to a shorter repeat course.